MedPath

Biomarker study using exosomes to predict the effect of immune checkpoint inhibitors on primary lung cancer

Not Applicable
Recruiting
Conditions
ung cancer
Registration Number
JPRN-UMIN000039609
Lead Sponsor
Juntendo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biomarker for predicting the effects and the adverse events of immune checkpoint inhibitors
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath